Skip to main content

Peer Review reports

From: Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial)

Original Submission
23 Oct 2023 Submitted Original manuscript
7 Nov 2023 Reviewed Reviewer Report
13 Nov 2023 Reviewed Reviewer Report
29 Nov 2023 Author responded Author comments - Xufeng Guo
Resubmission - Version 2
29 Nov 2023 Submitted Manuscript version 2
3 Dec 2023 Reviewed Reviewer Report
11 Dec 2023 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
12 Dec 2023 Editorially accepted
15 Dec 2023 Article published 10.1186/s12885-023-11747-9

You can find further information about peer review here.

Back to article page